Maternal vitamin D sufficiency and reduced placental gene expression in angiogenic biomarkers related to comorbidities of pregnancy

Journal of Steroid Biochemistry and Molecular Biology

Volumn 173, Issue , 2017, Pages 273-279

  Schulz, Elizabeth V ^a   Cruze, Lori ^b   Wei, Wei ^c   Gehris, John ^a   Wagner, Carol L ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b Charleston OB/GYN   (United States)

^c Deparment of Public Health Sciences   (United States)

Author keywords

Placenta; Preeclampsia; sFlt 1; Vascular endothelial growth factor; Vitamin D

Indexed keywords

25 HYDROXYVITAMIN D; CHORIONIC GONADOTROPIN BETA SUBUNIT; COLECALCIFEROL; COLECALCIFEROL 24 HYDROXYLASE; CYTOCHROME P450 FAMILY 27; GLUCOCORTICOID RECEPTOR ALPHA; MESSENGER RNA; PLACEBO; PROGESTERONE RECEPTOR B; PROSTAGLANDIN F; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 1; VITAMIN D RECEPTOR; 25-HYDROXYVITAMIN D; BIOLOGICAL MARKER; FLT1 PROTEIN, HUMAN; VASCULOTROPIN A; VITAMIN; VITAMIN D;

ADULT; AFRICAN AMERICAN; ANGIOGENESIS; ARTICLE; CAUCASIAN; CLINICAL ARTICLE; COMORBIDITY; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GENE EXPRESSION; HISPANIC; HUMAN; PLACENTA; POLYMERASE CHAIN REACTION; PREECLAMPSIA; PREGNANCY COMPLICATION; RANDOMIZED CONTROLLED TRIAL; VITAMIN BLOOD LEVEL; VITAMIN D METABOLISM; ANALOGS AND DERIVATIVES; BLOOD; GENETICS; METABOLISM; PREGNANCY; TRANSCRIPTION INITIATION; VITAMIN D DEFICIENCY; YOUNG ADULT;

ADULT; BIOMARKERS; CHOLECALCIFEROL; COMORBIDITY; DOWN-REGULATION; FEMALE; HUMANS; PLACENTA; PRE-ECLAMPSIA; PREGNANCY; RNA, MESSENGER; TRANSCRIPTIONAL ACTIVATION; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1; VITAMIN D; VITAMIN D DEFICIENCY; VITAMINS; YOUNG ADULT;

EID: 85013137849     PISSN: 09600760     EISSN: 18791220     Source Type: Journal    
DOI: 10.1016/j.jsbmb.2017.02.003     Document Type: Article

References (35)

1. Hollis, B.W., Wagner, C.L., Vitamin D and pregnancy: skeletal effects, nonskeletal effects, and birth outcomes. Calcif. Tissue Int. 92:2 (2013), 128–139, 10.1007/s00223-012-9607-4 PubMed PMID: 22623177.
2. Wagner, C.L., Taylor, S.N., Dawodu, A., Johnson, D.D., Hollis, B.W., Vitamin D and its role during pregnancy in attaining optimal health of mother and fetus. Nutrients 4:3 (2012), 208–230, 10.3390/nu4030208 PubMed PMID: 22666547; PubMed Central PMCID: PMC3347028.
3. Wagner, C.L., Baggerly, C., McDonnell, S., Baggerly, K.A., French, C.B., Baggerly, L., et al. Post-hoc analysis of vitamin D status and reduced risk of preterm birth in two vitamin D pregnancy cohorts compared with South Carolina March of Dimes 2009–2011 rates. J. Steroid Biochem. Mol. Biol. 155:Pt B (2016), 245–251, 10.1016/j.jsbmb.2015.10.022 PubMed PMID: 26554936.
4. Bodnar, L.M., Platt, R.W., Simhan, H.N., Early-pregnancy vitamin D deficiency and risk of preterm birth subtypes. Obstet. Gynecol. 125:2 (2015), 439–447.
5. Bodnar, L.M., Catov, J.M., Simhan, H.N., Holick, M.F., Powers, R.W., Roberts, J.M., Maternal vitamin D deficiency increases the risk of preeclampsia. J. Clin. Endocrinol. Metab. 92:9 (2007), 3517–3522, 10.1210/jc.2007-0718 Epub 2007/05/31. PubMed PMID: 17535985.
6. Qin, L.L., Lu, F.G., Yang, S.H., Xu, H.L., Luo, B.A., Does maternal Vitamin D deficiency increase the risk of preterm birth: a meta-analysis of observational studies. Nutrients, 8(5), 2016, 10.3390/nu8050301 PubMed PMID: 27213444; PubMed Central PMCID: PMCPMC4882713.
7. Hollis, B.W., Johnson, D., Hulsey, T.C., Ebeling, M., Wagner, C.L., Vitamin D supplementation during pregnancy: double-blind, randomized clinical trial of safety and effectiveness. J. Bone Miner. Res. 26:10 (2011), 2341–2357, 10.1002/jbmr.463 Epub 2011/06/28. PubMed PMID: 21706518; PubMed Central PMCID: PMCPMC3183324.
8. Mangin, M., Sinha, R., Fincher, K., et al. Inflammation and vitamin D: the infection connection. Inflammation Res. 63:10 (2014), 803–819 Epub 2014/07/23. 10.1007/s00011-014-0755-z. PubMed PMID: 25048990; PubMed Central PMCID: PMCPMC4160567.
9. Forrest, K.Y., Stuhldreher, W.L., Prevalence and correlates of vitamin D deficiency in US adults. Nutr. Res. (New York, NY) 31:1 (2011), 48–54 Epub 2011/02/12. 10.1016/j.nutres.2010.12.001. PubMed PMID: 21310306.
10. Holick, M.F., Shining light on the vitamin D: cancer connection IARC report. Dermato-Endocrinol. 1:1 (2009), 4–6 Epub 2010/01/05. PubMed PMID: 20046581; PubMed Central PMCID: PMCPMC2715200.
11. Mheid, Al I, Patel, R., Murrow, J., Morris, A., Rahman, A., Fike, L., et al. Vitamin D status is associated with arterial stiffness and vascular dysfunction in healthy humans. J. Am. Coll. Cardiol. 58:2 (2011), 186–192 Epub 2011/07/02. 10.1016/j.jacc.2011.02.051. PubMed PMID: 21718915; PubMed Central PMCID: PMCPMC3896949.
12. Bodnar, L.M., Catov, J.M., Simhan, H.N., Holick, M.F., Powers, R.W., Roberts, J.M., Maternal vitamin D deficiency increases the risk of preeclampsia. J. Clin. Endocrinol. Metab. 92:9 (2007), 3517–3522 Epub 2007/05/31. 10.1210/jc.2007-0718. PubMed PMID: 17535985; PubMed Central PMCID: PMCPMC4288954.
13. Haugen, M., Brantsaeter, A.L., Trogstad, L., Alexander, J., Roth, C., Magnus, P., et al. Vitamin D supplementation and reduced risk of preeclampsia in nulliparous women. Epidemiol. (Cambridge, Mass) 20:5 (2009), 720–726 Epub 2009/05/20.10.1097/EDE.0b013e3181a70f08. PubMed PMID: 19451820.
14. Robinson, C.J., Alanis, M.C., Wagner, C.L., Hollis, B.W., Johnson, D.D., Plasma 25-hydroxyvitamin D levels in early-onset severe preeclampsia. Am. J. Obstet. Gynecol. 203:4 (2010), e1–e6 366 Epub 2010/08/10. 10.1016/j.ajog.2010.06.036. PubMed PMID: 20692641; PubMed Central PMCID: PMCPMC3192365.
15. Mirzakhani, H., Litonjua, A.A., McElrath, T.F., O'Connor, G., Lee-Parritz, A., Iverson, R., et al. Early pregnancy vitamin D status and risk of preeclampsia. J. Clin. Invest. 126:12 (2016), 4702–4715 Epub 2016/11/15. 10.1172/jci89031. PubMed PMID: 27841759; PubMed Central PMCID: PMCPMC5127689.
16. Al-Garawi, A., Carey, V.J., Chhabra, D., Mirzakhani, H., Morrow, J., Lasky-Su, J., et al. The role of Vitamin D in the transcriptional program of human pregnancy. PloS One, 11(10), 2016, e0163832 Epub 2016/10/07. 10.1371/journal.pone.0163832. PubMed PMID: 27711190; PubMed Central PMCID: PMCPMC5053446.
17. Robinson, C.J., Wagner, C.L., Hollis, B.W., Baatz, J.E., Johnson, D.D., Association of maternal vitamin D and placenta growth factor with the diagnosis of early onset severe preeclampsia. Am. J. Perinatol. 30:3 (2013), 167–172 Epub 2012/08/10. 10.1055/s-0032-1322514. PubMed PMID: 22875657.
18. Jones, G., Prosser, D.E., Kaufmann, M., 25-Hydroxyvitamin D-24-hydroxylase (CYP24A1): its important role in the degradation of vitamin D. Arch. Biochem. Biophys. 523:1 (2012), 9–18 Epub 2011/11/22. 10.1016/j.abb.2011.11.003. PubMed PMID: 22100522.
19. Wyatt, S.M., Kraus, F.T., Roh, C.R., Elchalal, U., Nelson, D.M., Sadovsky, Y., The correlation between sampling site and gene expression in the term human placenta. Placenta 26:5 (2005), 372–379 Epub 2005/04/27. 10.1016/j.placenta.2004.07.003. PubMed PMID: 15850641.
20. Pidoux, G., Gerbaud, P., Laurendeau, I., Guibourdenche, J., Bertin, G., Vidaud, M., et al. Large variability of trophoblast gene expression within and between human normal term placentae. Placenta 25:5 (2004), 469–473 Epub 2004/04/15. 10.1016/j.placenta.2003.10.016. PubMed PMID: 15081642.
21. Andersen, C.L., Jensen, J.L., Orntoft, T.F., Normalization of real-time quantitative reverse transcription-PCR data: a model-based variance estimation approach to identify genes suited for normalization, applied to bladder and colon cancer data sets. Cancer Res. 64:15 (2004), 5245–5250 Epub 2004/08/04. 10.1158/0008-5472. can-04-0496. PubMed PMID: 15289330.
22. Yuan, J.S., Reed, A., Chen, F., Stewart, C.N. Jr., Statistical analysis of real-time PCR data. BMC Bioinf., 7, 2006, 85 Epub 2006/03/01. 10.1186/1471-2105-7-85. PubMed PMID: 16504059; PubMed Central PMCID: PMCPMC1395339.
23. Livak, K.J., Schmittgen, T.D., Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods (San Diego, Calif) 25:4 (2001), 402–408 Epub 2002/02/16. 10.1006/meth.2001.1262. PubMed PMID: 11846609.
24. Lu, F., Longo, M., Tamayo, E., Maner, W., Al-Hendy, A., Anderson, G.D., et al. The effect of over-expression of sFlt-1 on blood pressure and the occurrence of other manifestations of preeclampsia in unrestrained conscious pregnant mice. Am. J. Obstet. Gynecol. 196:4 (2007), e1–e7 396 discussion e7. Epub 2007/04/04. 10.1016/j.ajog.2006.12.024. PubMed PMID: 17403433.
25. Moore, A.G., Young, H., Keller, J.M., Ojo, L.R., Yan, J., Simas, T.A., et al. Angiogenic biomarkers for prediction of maternal and neonatal complications in suspected preeclampsia. J. Maternal-Fetal Neonatal Med. 25:12 (2012), 2651–2657 Epub 2012/08/07. 10.3109/14767058.2012.713055. PubMed PMID: 22861812.
26. Karumanchi, S.A., Epstein, F.H., Placental ischemia and soluble fms-like tyrosine kinase 1: cause or consequence of preeclampsia?. Kidney Int. 71:10 (2007), 959–961 Epub 2007/05/15. 10.1038/sj.ki.5002281. PubMed PMID: 17495934.
27. Levine, R.J., Lam, C., Qian, C., Yu, K.F., Maynard, S.E., Sachs, B.P., et al. Soluble endoglin and other circulating antiangiogenic factors in preeclampsia. N. Engl. J. Med. 355:10 (2006), 992–1005 Epub 2006/09/08. 10.1056/NEJMoa055352. PubMed PMID: 16957146.
28. Levine, R.J., Maynard, S.E., Qian, C., Lim, K.H., England, L.J., Yu, K.F., et al. Circulating angiogenic factors and the risk of preeclampsia. N. Engl. J. Med. 350:7 (2004), 672–683 Epub 2004/02/07. 10.1056/NEJMoa031884. PubMed PMID: 14764923.
29. Rana, S., Powe, C.E., Salahuddin, S., Verlohren, S., Perschel, F.H., Levine, R.J., et al. Angiogenic factors and the risk of adverse outcomes in women with suspected preeclampsia. Circulation 125:7 (2012), 911–919 Epub 2012/01/21. 10.1161/circulationaha.111.054361. PubMed PMID: 22261192; PubMed Central PMCID: PMCPMC3319742.
30. Vatten, L.J., Eskild, A., Nilsen, T.I., Jeansson, S., Jenum, P.A., Staff, A.C., Changes in circulating level of angiogenic factors from the first to second trimester as predictors of preeclampsia. Am. J. Obstet. Gynecol. 196:3 (2007), e1–e6 239 Epub 2007/03/10. 10.1016/j.ajog.2006.10.909. PubMed PMID: 17346536.
31. Engels, T., Pape, J., Schoofs, K., Henrich, W., Verlohren, S., Automated measurement of sFlt1, PlGF and sFlt1/PlGF ratio in differential diagnosis of hypertensive pregnancy disorders. Hypertens. Pregnancy 32:4 (2013), 459–473 Epub 2013/08/21. 10.3109/10641955.2013.827205. PubMed PMID: 23957293.
32. Stepan, H., Hund, M., Gencay, M., Denk, B., Dinkel, C., Kaminski, W.E., et al. A comparison of the diagnostic utility of the sFlt -1/PlGF ratio versus PlGF alone for the detection of preeclampsia/HELLP syndrome. Hypertens. Pregnancy, 2016, 1–11 Epub 2016/03/31. 10.3109/10641955.2016.1141214. PubMed PMID: 27028698.
33. Zeisler, H., Llurba, E., Chantraine, F., Vatish, M., Staff, A.C., Sennstrom, M., et al. Predictive value of the sFlt-1:PlGF ratio in women with suspected preeclampsia. N. Engl. J. Med. 374:1 (2016), 13–22 Epub 2016/01/07. 10.1056/NEJMoa1414838. PubMed PMID: 26735990.
34. Gram, A., Hoffmann, B., Boos, A., Kowalewski, M.P., Expression and localization of vascular endothelial growth factor A (VEGFA) and its two receptors (VEGFR1/FLT1 and VEGFR2/FLK1/KDR) in the canine corpus luteum and utero-placental compartments during pregnancy and at normal and induced parturition. Gen. Comp. Endocrinol. 223 (2015), 54–65 Epub 2015/09/29. 10.1016/j.ygcen.2015.09.020. PubMed PMID: 26414127.
35. Zerwekh, J.E., Blood biomarkers of vitamin D status. Am. J. Clin. Nutr. 87:4 (2008), 1087S–1091S Epub 2008/04/11. PubMed PMID: 18400739.